The Korean influenza national immunization program

History and present status

Jae Won Yun, Ji Yun Noh, Joon-Young Song, Chaemin Chun, Yunju Kim, Hee-Jin Cheong

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

The Korean influenza national immunization program was first established as an interim program in 1997, administering the influenza vaccine to low-income elderly adults. In 2005, the program assumed its present form of providing free influenza vaccination to adults aged ≥65 years. After turning over the influenza vaccination for elderly adults to the private sectors in 2015, the influenza vaccination coverage rate among this population increased to > 80%. In addition, after the 2009 H1N1 influenza epidemic crisis, the vaccine was domestically produced. By reaching a 75% vaccination coverage rate in the target groups, it was possible to put an end to the influenza pandemic and fix the shortcomings of the system that existed at that time. The influenza vaccination program, provided free of cost, was extended to include infants aged < 12 months in 2016 and ≤59 months in 2017 in order to reduce the influenza burden in these populations. However, the vaccine effectiveness remains low despite the high vaccination rates in elderly adults. Therefore, several areas, such as the adoption of quadrivalent influenza vaccine, adjuvanted influenza vaccine, and high-dose influenza vaccine and the expansion of vaccination target groups, still need to be addressed.

Original languageEnglish
Pages (from-to)247-254
Number of pages8
JournalInfection and Chemotherapy
Volume49
Issue number4
DOIs
Publication statusPublished - 2017 Dec 1

Fingerprint

Immunization Programs
Human Influenza
History
Vaccination
Influenza Vaccines
Vaccines
Private Sector
Pandemics
Population
Costs and Cost Analysis

Keywords

  • History
  • Immunization
  • Influenza
  • Korea
  • Vaccination

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

The Korean influenza national immunization program : History and present status. / Yun, Jae Won; Noh, Ji Yun; Song, Joon-Young; Chun, Chaemin; Kim, Yunju; Cheong, Hee-Jin.

In: Infection and Chemotherapy, Vol. 49, No. 4, 01.12.2017, p. 247-254.

Research output: Contribution to journalReview article

@article{df3082f6e6dd4c799123fe138351ab8a,
title = "The Korean influenza national immunization program: History and present status",
abstract = "The Korean influenza national immunization program was first established as an interim program in 1997, administering the influenza vaccine to low-income elderly adults. In 2005, the program assumed its present form of providing free influenza vaccination to adults aged ≥65 years. After turning over the influenza vaccination for elderly adults to the private sectors in 2015, the influenza vaccination coverage rate among this population increased to > 80{\%}. In addition, after the 2009 H1N1 influenza epidemic crisis, the vaccine was domestically produced. By reaching a 75{\%} vaccination coverage rate in the target groups, it was possible to put an end to the influenza pandemic and fix the shortcomings of the system that existed at that time. The influenza vaccination program, provided free of cost, was extended to include infants aged < 12 months in 2016 and ≤59 months in 2017 in order to reduce the influenza burden in these populations. However, the vaccine effectiveness remains low despite the high vaccination rates in elderly adults. Therefore, several areas, such as the adoption of quadrivalent influenza vaccine, adjuvanted influenza vaccine, and high-dose influenza vaccine and the expansion of vaccination target groups, still need to be addressed.",
keywords = "History, Immunization, Influenza, Korea, Vaccination",
author = "Yun, {Jae Won} and Noh, {Ji Yun} and Joon-Young Song and Chaemin Chun and Yunju Kim and Hee-Jin Cheong",
year = "2017",
month = "12",
day = "1",
doi = "10.3947/ic.2017.49.4.247",
language = "English",
volume = "49",
pages = "247--254",
journal = "Infection and Chemotherapy",
issn = "2093-2340",
publisher = "Taehan Kamyom Hakhoe, Taehan Hwahak Yopop Hakhoe",
number = "4",

}

TY - JOUR

T1 - The Korean influenza national immunization program

T2 - History and present status

AU - Yun, Jae Won

AU - Noh, Ji Yun

AU - Song, Joon-Young

AU - Chun, Chaemin

AU - Kim, Yunju

AU - Cheong, Hee-Jin

PY - 2017/12/1

Y1 - 2017/12/1

N2 - The Korean influenza national immunization program was first established as an interim program in 1997, administering the influenza vaccine to low-income elderly adults. In 2005, the program assumed its present form of providing free influenza vaccination to adults aged ≥65 years. After turning over the influenza vaccination for elderly adults to the private sectors in 2015, the influenza vaccination coverage rate among this population increased to > 80%. In addition, after the 2009 H1N1 influenza epidemic crisis, the vaccine was domestically produced. By reaching a 75% vaccination coverage rate in the target groups, it was possible to put an end to the influenza pandemic and fix the shortcomings of the system that existed at that time. The influenza vaccination program, provided free of cost, was extended to include infants aged < 12 months in 2016 and ≤59 months in 2017 in order to reduce the influenza burden in these populations. However, the vaccine effectiveness remains low despite the high vaccination rates in elderly adults. Therefore, several areas, such as the adoption of quadrivalent influenza vaccine, adjuvanted influenza vaccine, and high-dose influenza vaccine and the expansion of vaccination target groups, still need to be addressed.

AB - The Korean influenza national immunization program was first established as an interim program in 1997, administering the influenza vaccine to low-income elderly adults. In 2005, the program assumed its present form of providing free influenza vaccination to adults aged ≥65 years. After turning over the influenza vaccination for elderly adults to the private sectors in 2015, the influenza vaccination coverage rate among this population increased to > 80%. In addition, after the 2009 H1N1 influenza epidemic crisis, the vaccine was domestically produced. By reaching a 75% vaccination coverage rate in the target groups, it was possible to put an end to the influenza pandemic and fix the shortcomings of the system that existed at that time. The influenza vaccination program, provided free of cost, was extended to include infants aged < 12 months in 2016 and ≤59 months in 2017 in order to reduce the influenza burden in these populations. However, the vaccine effectiveness remains low despite the high vaccination rates in elderly adults. Therefore, several areas, such as the adoption of quadrivalent influenza vaccine, adjuvanted influenza vaccine, and high-dose influenza vaccine and the expansion of vaccination target groups, still need to be addressed.

KW - History

KW - Immunization

KW - Influenza

KW - Korea

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=85039987234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039987234&partnerID=8YFLogxK

U2 - 10.3947/ic.2017.49.4.247

DO - 10.3947/ic.2017.49.4.247

M3 - Review article

VL - 49

SP - 247

EP - 254

JO - Infection and Chemotherapy

JF - Infection and Chemotherapy

SN - 2093-2340

IS - 4

ER -